Details

Autor(en) / Beteiligte

• Inojosa, Hernan
• Ziemssen, Tjalf

Titel

Current and innovative Approaches to Multiple Sclerosis Therapy

Ist Teil von

• Fortschritte der Neurologie-Psychiatrie, 2024-01, Vol.92 (1-02), p.41

Ort / Verlag

Germany

Erscheinungsjahr

2024

Quelle

MEDLINE

Beschreibungen/Notizen

• The landscape of immunotherapies in the management of Multiple Sclerosis (MS) is currently particularly dynamic. Over 21 immunotherapeutic options are approved by the European Meidcines Agency (EMA), Food and Drug Administration (FDA) and newer approaches are ongoing in clinical trials. With advancements in the understanding of MS pathophysiology and further development of diagnosis criteria, newer and more specific disease-modifying therapies (DMTs) have emerged in recent years. The selection and timing of proper therapeutic approaches is increasingly complex. We provide an overview of the available immunotherapies for a personalized MS treatment and discuss practical insights into their application. The importance of early intervention, distinction between escalation and induction approaches, and consideration of high-efficacy treatments for specific patient groups are in discussed. We emphasize the significance of a patient-centered approach, taking into account various factors such as comorbidities, family planning, administration preferences and potential side effects in treatment decision-making.